Coya Therapeutics Announces the Completion of a Controlled Phase 2 Study of Low Dose Interleukin-2 (LD IL-2) in Patients with Alzheimer’s Disease
This investigator-initiated, double-blind, placebo-controlled study (funded by the Gates Foundation and Alzheimer’s Association) evaluates the safety and tolerability,... Read more.
PQE Group US Earns Great Place to Work Certification™
Recognition is obtained for third consecutive year ROCKVILLE, Md.–(BUSINESS WIRE)–PQE Group is proud to announce that, for the third consecutive year,... Read more.
CORRECTING and REPLACING Zyxel Networks Makes WiFi 7 Easier and More Affordable for Small- and Medium-Sized Businesses
NWA130BE BE11000 WiFi 7 Access Point Provides Ease of Management and Robust Feature Set to Easily Add WiFi 7 Technology to Existing Networks ANAHEIM, Calif.–(BUSINESS... Read more.
Holden Strub Joins Alliant Insurance Services’ Employee Benefits Team
Voluntary benefits focus adds strength to clients’ recruiting and retention efforts IRVINE, Calif.–(BUSINESS WIRE)–#AlliantInsurance–Holden Strub... Read more.
Multiple Abstracts Highlighting Vir Biotechnology’s Latest Hepatitis Delta & B Data Accepted for Presentation at the EASL Congress 2024
– Company to present important new data from the Phase 2 SOLSTICE chronic hepatitis delta trial – – Conference call scheduled for June 5, 2024, at 6:00 a.m.... Read more.
SAIC Schedules First Quarter Fiscal Year 2025 Earnings Conference Call for June 3 at 10 A.M. ET
RESTON, Va.–(BUSINESS WIRE)–Science Applications International Corp. (NASDAQ: SAIC) is scheduled to issue its first quarter fiscal year 2025 results... Read more.
Fujitsu Scales Automation Enterprise-Wide with UiPath to Meet Digital Transformation Goals
With UiPath as one of the solution partners of Fujitsu’s FujiTra project, Fujitsu aims to increase workforce efficiency by 40% NEW YORK–(BUSINESS WIRE)–UiPath... Read more.
Otsuka to Terminate Development of AVP-786
TOKYO & PRINCETON, N.J.–(BUSINESS WIRE)–Otsuka Pharmaceutical Co., Ltd. (Otsuka) and its U.S. subsidiary, Otsuka Pharmaceutical Development &... Read more.
Atalanta Therapeutics Expands Executive Team with Appointments of Chief Medical Officer and Chief Financial Officer
– Serena Hung, M.D., and Jeffrey Young will support company’s continued progress, including two planned IND submissions in 2025 – BOSTON–(BUSINESS... Read more.
Is this 911 call truly an emergency? ESO Research looks at dispatch protocols and patient outcomes to understand 911 prioritization measures
Study represents a significant step in enhancing emergency response amid rising call volume and resource constraints. AUSTIN, Texas–(BUSINESS WIRE)–ESO,... Read more.